This week's Fierce LifeSci is brought to you by Catalent.

Webinar: Plasmid Platform Facilitates Transition to Clinic

Tuesday, March 29, 2022 | 11am ET / 8am PT

The demand for plasmid DNA, a critical component to many biological therapeutics, has grown concurrently with advances and successes in cell, gene and mRNA therapies. Join Catalent's plasmid DNA expert to learn how a plasmid manufacturing platform process can support early activities and the transition toward GMP production.

Webinar topics include:

The features of a plasmid manufacturing platform process
How starting at the lead identification and tox phases support and expedite the transition towards GMP manufacturing
The advantages of securing plasmid bioproduction services that are fully integrated within viral vector and cell therapy manufacturing capabilities

You are currently subscribed as newsletter@newslettercollector.com
If you no longer wish to receive promotions from Fierce LifeSciences, simply unsubscribe.
Refer to our Privacy Policy.

Fierce LifeSciences is a division of Questex LLC.
685 3rd Ave 21st Floor New York, NY 10017
© 2021 Questex LLC. All Rights Reserved.
Reproduction in whole or in part is prohibited without written permission.